Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA approves next-gen mitral valve from Medtronic
The Mosaic Neo mitral bioprosthesis can be implanted through sternotomy, minimally invasive cardiac surgery or robotic access.
PFA's dominance and other key electrophysiology trends on display at Heart Rhythm 2026
Heart Rhythm 2026 Program Chair DJ Lakkireddy, MD, spoke to Cardiovascular Business during the conference about several key EP trends.
FTC settles antitrust lawsuit against private equity-backed anesthesiology chain
Federal regulators alleged that U.S. Anesthesia Partners—a portfolio company of Welsh, Carson, Anderson & Stowes—engaged in a “roll-up scheme” in Texas that effectively eliminated the competition. The company denies the allegations, but has agreed to undisclosed terms that would see the lawsuit resolved.
IV fluids recalled over possible contamination—patients face risk of vascular complications
Particulate matter may be present in certain 1-liter containers of B. Braun Medical's Lactated Ringer's Injections. If this enters a patient's circulatory system, it could lead to a series of adverse events.
FDA warns public about vascular device after 3 deaths
The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.

FDA approves next-gen mitral valve from Medtronic

The Mosaic Neo mitral bioprosthesis can be implanted through sternotomy, minimally invasive cardiac surgery or robotic access.

Heart Rhythm 2026 Program Chair Dhanunjaya "DJ" Lakkireddy, MD, MBA, FHRS, Executive Medical Director, Kansas City Heart Rhythm Institute, and professor of medicine at the University of Kansas Health System, offers an overview of key trends in electrophysiology (EP) technology.

PFA's dominance and other key electrophysiology trends on display at Heart Rhythm 2026

Heart Rhythm 2026 Program Chair DJ Lakkireddy, MD, spoke to Cardiovascular Business during the conference about several key EP trends.

Michigan has become the 20th state to opt out from federal regulations that require physician supervision of certified registered nurse anesthetists (CRNAs). The move was made to ensure access to value-based, high-quality care across the state, but it is being opposed by the Michigan Society of Anesthesiologists (MSA) and several other physician groups. Image from the American Association of Nurse Anesthesiology (AANA)

FTC settles antitrust lawsuit against private equity-backed anesthesiology chain

Federal regulators alleged that U.S. Anesthesia Partners—a portfolio company of Welsh, Carson, Anderson & Stowes—engaged in a “roll-up scheme” in Texas that effectively eliminated the competition. The company denies the allegations, but has agreed to undisclosed terms that would see the lawsuit resolved.

IV fluids recalled over possible contamination—patients face risk of vascular complications

Particulate matter may be present in certain 1-liter containers of B. Braun Medical's Lactated Ringer's Injections. If this enters a patient's circulatory system, it could lead to a series of adverse events.

FDA warns public about vascular device after 3 deaths

The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.

Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform

Ultreon 3.0 was built to capture and evaluate OCT images, providing real-time guidance during complex PCI procedures.

The Society for Cardiovascular Angiography and Interventions (SCAI) is entering a new chapter as Dawn Abbott, MD, MSCAI, who assumeed the presidency this week with a focus on strengthening the future of interventional cardiology through workforce development, expanded training pathways and continued efforts to broaden inclusion in the specialty. #SCAI2026 #SCAI26

New SCAI President Dawn Abbott outlines workforce training and inclusion priorities

SCAI President Dawn Abbott, MD, MSCAI, aims to turn attention toward the long-term sustainability of the interventional cardiology field.

FDA recall medical device recall product recall

Boston Scientific pacemakers recalled again—software update now available

The new Class I recall, which includes more than 1.4 million devices, is related to an issue first announced back in 2024. Updating the software should address the issue going forward, though some patients may still require an early replacement.